Cases 41 - 50 of 85
Boehringer Ingelheim Pharmaceuticals Inc., et al. v. Zydus Pharmaceuticals (USA) Inc., et al.
as 1:2019cv01501
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Cadila Healthcare Limited
as 1:2019cv01295
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2019cv00760
Defendant:
Zydus Worldwide DMCC, Cadila Healthcare, Ltd. and Zydus Pharmaceuticals (USA) Inc.
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Cause Of Action: 35 U.S.C. § 271
OSI Pharmaceuticals, LLC et al v. Zydus Pharmaceuticals (USA) Inc.
as 1:2019cv00741
Plaintiff:
Genentech, Inc. and OSI Pharmaceuticals, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH v. Zydus Pharmaceuticals (USA) Inc.
as 1:2019cv00333
Defendant:
Zydus Pharmaceuticals (USA) Inc.
Plaintiff:
Biogen International GmbH
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Zydus Pharmaceuticals (USA) Inc., et al.
as 1:2019cv00314
Plaintiff:
Merck Sharp & Dohme Corp.
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2018cv01763
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant:
Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
